CClinicalTrials.gg
CompletedNCT02362061Updated Mar 24, 2017

3D Ultrasound Measurement of Junctional Zone Thickness and Its Relation to Implantation Success

An observational study in Infertility, sponsored by Cairo University. Completed at 1 site in Egypt. Open to female participants aged 21 Years to 40 Years. Per ClinicalTrials.gov, last updated 2017-03-24.

Sponsored by Cairo University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
21 Years to 40 Years
Sex
Female
01

Study summary

100 patients aged 21-40 years old, diagnosed as primary or secondary infertility . These patients are then assigned to receive fertility treatment (ovulation induction, ICSI, intrauterine insemination and IVF). They undergo a 3D vaginal ultrasound before treatment to measure the junctional zone thickness and followed up after treatment to determine the rate of implantation.

02

Conditions studied

  • Infertility

Browse trials for

Keywords

  • junctional zone
  • implantation
  • three D ultraosund
  • Assisted Reproductive Technology
  • Pregnancy
03

In context

Infertility

2,506 studies on the registry are indexed under Infertility; 407 are open to participants now.

This study's enrollment of 100 is below the median of 200 across 714 observational studies indexed under Infertility.

Browse Infertility studies →

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

100 patients aged 21-40 years old, diagnosed as primary or secondary infertility due to the following causes of infertility; ( Pelvic Inflammatory disease, dysovulation , tubal infertility, unexplained infertility, combined infertility or due to male factor ).

Inclusion criteria

  • infertile women

Exclusion criteria

Exclusion Criteria:

  • congenital uterine anomalies medical disease contraindicating pregnancy
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (actual)
Patient registry
No

Groups and cohorts

  • pregnant

    These patients are then assigned to receive fertility treatment (ovulation induction, ICSI, intrauterine insemination and IVF). They undergo a 3D vaginal ultrasound before treatment to measure the junctional zone thickness and followed up after treatment to determine the rate of implantation and they became pregnant

    Radiation: 3D ultrasound

  • Non pregnant

    These patients are then assigned to receive fertility treatment (ovulation induction, ICSI, intrauterine insemination and IVF). They undergo a 3D vaginal ultrasound before treatment to measure the junctional zone thickness and followed up after treatment to determine the rate of implantation and they remained non pregnant

    Radiation: 3D ultrasound

Interventions

  • Radiation3D ultrasound

    ultrasound to measure the thickness of the junctional zone at day 21 of the cycle

06

What researchers measure

Primary outcomes

  1. pregnancy rate

    Time frame: 14 days after evaluation

Secondary outcomes

  1. healthy pregnancy

    Time frame: 6 weeks after pregnancy confirmation by pregnancy test

07

Study locations

1 site
  • Kasr Alainy medical school
    Cairo, 12151, Egypt
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 24, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02362061
Lead sponsor
Cairo University
Responsible party
Ahmed Maged (Assistant professor, Cairo University) — Principal investigator
First posted
Feb 12, 2015
Start date
Feb 2014
Primary completion
Dec 2016
Completion
Jan 2017
Last update
Mar 24, 2017

Study contacts

Ahmed M Maged, MD
principal investigator · Kasr Alainy medical school

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion